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Abstract: An epizootic of eastern equine encephalitis (EEE) virus infection in 1984 resulted in death for 
7 of 39 captive whooping cranes (Crus americana) at the Patuxent Wildlife Research Center. This repre-
sented the first known whooping crane deaths associated with this arboviral disease and posed a serious 
risk to the continued propagation of this endangered species. Subsequent research and surveillance pro-
cedures initiated to prevent EEE viral infections in captive whooping cranes included vector surveillance 
and control, virus surveillance through use of sentinel birds, immunoassays for rapid detection of EEE 
virus antigen in bird sera and in mosquitoes, and testing of an EEE virus vaccine in whooping cranes. 
Based on results of these efforts, we are optimistic that EEE virus can be effectively monitored and pre-
vented and thus the risk of future infections can be reduced among captive whooping cranes. 
An outbreak of eastern equine encephalitis 
(EEE) virus at the Patuxent Wildlife Research Cen-
ter (Center), U. S. Fish and Wildlife Service, Lau-
rel, Maryland, USA during the late summer and 
fall of 1984 resulted in death of 7 of 39 endangered 
whooping cranes (Dein et a1. 1986; Carpenter et a1. 
1987). Viral assays of tissues from 5 of the cranes 
yielded EEE virus. Epizootiological observations 
Proc. 1988 N. Am Crane Workshop 
following the outbreak revealed that 14 (44%) of 
the 32 surviving whooping cranes and 13 (34%) of 
38 co-resident sandhill cranes (G. canadensis) had 
EEE virus neutralizing (N) antibody (Clark et a1. 
1987). No clinical signs were observed in the sur-
viving 32 w):1ooping cranes, and no mortality or 
clinical signs were observed in 248 sandhill cranes 
located near the whooping cranes. EEE virus has 
1 Present Address: Department of Surgery and Medicine, College of Veternary Medicine, Kansas State University, Manhattan, 
KS 66506 
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been responsible for extensive mortality in several 
avian speciesinc1uding the chukar (Alectoris chukar) 
(Moulthrop & Gordy 1960), house sparrow (Passer 
domesticus) (Byrne et a1. 1961), and ring-necked 
pheasant (Phasianus colchicus) (Sussman et a1. 1958), 
all exotic species introduced into the U.S. However, 
the whooping crane losses represent the first re-
ported deaths associated with a natural EEE viral 
infection in an avian species indigenous to North 
America. 
The EEE virus is enzootic in the eastern and 
northcentral United States and adjacent Canada, in 
scattered areas of Central and South America, and 
in the Caribbean region (Monath 1979). The enzo-
otic cycle involves transmission of virus between 
wild birds by mosquitoes, with occasional epizoot-
ics in equines. Culiseta melanura is considered the 
primary enzootic vector of EEE virus in North 
America (Hayes 1961; Williams et a1. 1972). Culiseta 
melanura breeds in heavily-shaded seepage areas 
(i.e. in root holes under fallen trees) associated with 
freshwater swamps. Other aspects of the ecology 
of C. melanura have been previously detailed (Jo-
seph & Bickley 1969). Immediately after the 
epizootic in the whooping cranes, EEE virus N 
antibody was detected in wild birds captured at the 
Center. Serum from one whooping crane and two 
sandhill cranes bled at the Center in 1974 also had 
N antibody to EEE virus. During earlier studies at 
the Center, EEE virus antibody also was found in 
5 species of wild birds (Herman 1962). These find-
ings suggested that EEE virus was enzootic and 
thus posed a serious risk to the future successful 
propagation of the whooping crane at the Center 
(Clark et a1. 1987). To minimize this risk, a multi-
faceted strategy was initiated to prevent future EEE 
viral infection in the captive cranes. This 
multiagency effort included vector surveillance 
and control, serological surveillance with sentinel 
northern bobwhite (Colinus virginianus), virological 
surveillance in C. melanura, and a program for vac-
°cination of cranes with an EEE viral vaccine. This 
paper reports on the research progress and moni-
toring procedures implemented at the Center to 
prevent future EEE viral infections in captive 
whooping cranes. 
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METHODS AND MATERIALS 
Vector Surveillance 
Aerial and ground surveys were conducted in 
March and April 1985 at the Center, Fort George 
G. Meade (FGGM), and adjacent areas to locate 
potential overwintering larvae at C. melanura pro-
duction sites. During the spring, summer and fall 
from 1985-1987, identified production sites were 
monitored and surveys were conducted to locate 
additional sites. 
Adult C. melanura abundance was monitored 
using standard CDC light traps augmented with a 
CO2 attractant (dry ice) from May through Novem-
ber 1985-1987. Light traps were placed in two ar-
eas within the Center's crane propagation area and 
along the 7.3 km common boundary between the 
Center and FGGM, an area with potential breed-
ing and overwintering habitat for C. melanura. 
Eleven trap sites were established at FGGM in 
1985,4 of which also were used in 1986 and 1987, 
and were checked 2 nights per week. Five to 7 traps 
were operated 1 night per week in all 3 years at the 
Center. Additionally, up to 3 standard New Jersey 
light traps and up to 19 0.28 m2 resting boxes (see 
Edman et a1. 1968) were used intermittently for 
supplemental surveillance at the Center. 
Vector Control 
In 1985, 5 sites positive for C. melanura larvae 
and 35 other potentially positive sites were treated 
with Altosida briquets (7.9% methoprene). Thirteen 
days after application of this insect growth regu-
lator, larvae were collected for post-treatment 
evaluation. Flit MLOb (98.5% mineral oil) was also 
applied to these larva-positive sites. Post-treatment 
larval behavior was observed and recorded as a 
qualitative indicator of treatment effectiveness. 
Control of adult C. melanura was attempted in 
August 1985, on a 4-hectare plot at FGGM using 
Dursban 4Ec (41.2% chlorpyrifos) at a rate of 120 
rnl per acre and delivered with a Bean Model 100Kd 
mistblower. Change in pre- and post-treatment 
collections in CDC light traps were used as an in-
dication of insecticide treatment efficacy. 
Q Zoecon Corporation, Palo Alto, California. Use of trade names does not imply endorsement by U.S. Government agency. 
b Exxon Company, Houston, Texas. 
CDow Chemical Company, Midland, Texas. 
d FMC Corporation, Jonesboro, Arkansas. 
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Serological Surveillance 
To monitor EEE virus activity during the sum-
mer and fall of 1985, 1986, and 1987, 5 seronegative 
adult northern bobwhites were retained in each of 
4 wire mesh cages positioned along the northern 
perimeter of the Center adjacent to FGGM. The 
sentinel bobwhites were bled weekly, biweekly, or 
monthly and the serum component assayed by ei-
ther the plaque reduction neutralization test 
(PRNT) for antibody against EEE virus (Clark et al. 
1987) or the tissue culture neutralization test. All 
sera were heat treated and screened for antibody 
at 1:10 by the PRNT and at 1:4 by the tissue cul-
ture neutralization test. 
Viral Surveillance 
A viral surveillance program was conducted to 
isolate and identify EEE virus from mosquitoes and 
crane sera to monitor transmission activity by 
mosquitoes and to provide corroborative informa-
tion for diagnosis of crane infections. During these 
analyses, a traditional cell culture bioassay was 
compared with a newly developed antigen de-
tected enzyme immunoassay (EIA). In 1985, the 
EIA for detecting EEE virus in C. melanura was 
initiated with mosquitoes collected from the Cen-
ter and FGGM. In addition, 86 whooping and san-
dhill crane serum samples, including 2 from 
whooping cranes that died in the 1984 epizootic, 
were analyzed using the EIA. Laboratory proce-
dures for the EIA have been described by Scott et 
al. (1987). 
Vaccination Program 
Although a vaccination program was consid-
ered feasible, existing information on EEE vaccines 
was derived primarily from studies of human sub-
jects (Maire et al. 1970). Data indicated that the 
vaccine was safe for use in humans, and that neu-
tralizing antibody was elicited, but boosters were 
required to sustain detectable antibody. While lim-
ited vaccine studies have been attempted for pre-
vention of EEE in pheasants, results were inconclu-
sive and based only on a single vaccination 
(Sussman et al. 1958; Snoeyenbos et al. 1978; Eisner 
& Nusbaum 1983). Therefore, in order to determine 
the effect of administering a formalin-inactivated 
EEE vaccine to whooping cranes, sandhill cranes 
were used in preliminary studies to assess safety 
and to determine magnitude and duration of anti-
body following different routes of vaccination. 
E 
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Three routes of inoculation (intramuscular [1M] 
subcutaneous, and intravenous), safety of the vac-
cine, and various dosage regimens were tested 
(Clark et al. 1987). All serum samples were assayed 
for EEE virus N antibody using the PRNT in Vero 
(African green monkey kidney) cells (Clark et al. 
1986). An 80% or more reduction of the virus dose 
by a specific dilution of crane serum was consid-
ered evidence of EEE virus N antibody. 
In 1985, all (n = 15) EEE viral N antibody-
seronegative whooping cranes at the Center and 4 
whooping cranes with pre-existing, naturally ac-
quired N antibody received an 1M injection of 0.5 
ml of vaccine followed by a 1.0 ml booster 1M 30 
days later (Clark et al. 1987). After 6 months, these 
whooping cranes were rebled and given 1.0 ml of 
vaccine 1M. In July 1986 and 1987, all whooping 
cranes over one year of age were bled via jugular 
venipuncture and administered 1.0 ml of EEE vi-
rus vaccine 1M. These birds were rebled 30 days 
post vaccination, and those with titers <1:10 were 
revaccinated. Young-of-the-year were administered 
0.5 ml and 1.0 ml vaccine approximately 30 days 
apart beginning in August or September. All serum 
samples were evaluated for hemagglutination-in-
hibition (HI) antibody against EEE virus and/or 
were assayed for EEE virus N antibody using the 
PRNT (Clark et al. 1987). 
RESULTS 
Vector Surveillance 
The initial aerial space survey of the Center and 
FGGM identified habitat at FGGM which appeared 
suitable for overwintering C. melanura within a 4 
km radius of the Center's crane propagation area. 
Subsequently, ground surveys confirmed the pres-
ence of fourth instar C. melanura larvae in 5 (11 %) 
of 44 sites sampled. Larval numbers ranged from 
1 to greater than 100 per site. Periodic larval sam-
pling was performed within a 5.6 km radius of the 
cranes through 1987, but no new C. melanura larva-
positive sites were found. 
From 1985 to 1987, 122,035 mosquitoes were 
collected at the Center and FGGM, with 73,350, 
18,175 and 30,510 mosquitoes collected in 1985, 
1986 and 1987, respectively (Table 1). During the 
3 years of vector surveillance, C. melanura com-
prised 2.3% of all mosquitoes collected (Table 1). 
Culiseta melanura comprised 2.3% of the species 
composition in 1985, 3.1 % in 1986J and 1.9% in 
1987. Female C. melanura were collected from mid-
May through late October with the greatest num-
1 9 8 8 c R A N 
ber found from late August through early Septem-
ber. At the collection sites in the Center's crane 
propagation area, C. melanura was rarely collected. 
Coquillettiditl perturbans comprised 20.7% to 41.5% 
of the annual collections and was the single most 
abundant species. 
Vector Control 
Because vector control activities were only con-
ducted on a limited scale, evaluations of th~ con-
trol efforts were considered preliminary. All larvae 
from a sample of fourth ins tar C. melanura (n = 18) 
collected from a site treated with methoprene failed 
to develop past the pupal stage. Mineral oil ap-
peared to effect C. melanura larval respiration in 
treated sites, although the surface oil film did not 
last for more than 2 or 3 days as a result of pre-
cipitation and wind. An approximately 4-fold in-
crease between the pre-and post-treatment adult C. 
melanura trap index at one treatment site indicated 
that a single application of chlorpyrifos for adult 
control did not reduce the C. melanura popUlation 
to below the pre-treatment level. 
Serologic Surveillance 
All sentinel bobwhite sera obtained in 1985, 1986 
(August to October) and 1987 were negative for 
EEE virus antibody. 
Viral Surveillance 
A total of 910 adult female C. melanura were 
collected at the Center and FGGM during 1985 and 
assayed for EEE virus in 133 pools. No EEE virus 
was isolated in 2 different cell culture bioassay 
systems or by the EIA. Results from an evaluation 
of the EIA using mosquitoes collected elsewhere in 
Maryland indicate that the test was effective; there 
were no false positives or false negative results 
(Scott et al. 1987). In addition, the same EIA pro-
cedure correctly identified EEE virus antigen from 
2 whooping crane tissue specimens that contained 
infectious virus (Scott & Olson 1986). Both cranes 
had died during the 1984 epizootics. 
Vaccination Program 
The formalin-inactivated EEE vaccine produced 
antibody in cranes following 1M vaccinations, 
whereas subcutaneous and intravenous routes 
failed to elicit a response (Clark et al. 1987). Ad-
verse reactions to the vaccine were not observed 
E 
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in the 1M or subcutaneous vaccinated cranes. How-
ever, the intravenous inoculated cranes developed 
various degrees of temporary ataxia within 15 
minutes. 
Among the 32 whooping cranes that survived 
the EEE epiwotic in 1984, 14 had N antibody to 
EEE virus, thus indicating that these cranes were 
naturally infected either during or prior to the 
epizootic. The antibody response for 4 following 
vaccination with the EEE vaccine was character-
ized by a rapid and, in general, sustained high 
antibody titers that differed from the low transitory 
pattern exhibited by the seronegative cranes (Clark 
et al. 1987). This demonstrated that the vaccine was 
immunogenic and that the antibody detected fol-
lowing vaccination of seronegative cranes was elic-
ited by the EEE vaccine, rather than possible expo-
sure to a natural EEE viral infection. 
Because it was determined that a primary and 
booster vaccination were necessary to sustain de-
tectable antibody, this regime initially was used in 
15 seronegative whooping cranes. Only 1 of 12 
cranes tested following primary vaccination devel-
oped detectable antibody, whereas 10 of the other 
11 cranes had antibodies 60 days following admin-
istration of a booster on day 30. Thereafter, anti-
body titers waned, such that only 2 of 14 cranes 
had detectable antibody on day 180 post-vaccina-
tion. After a second booster on day 180, all cranes 
tested( n=13) had detectable antibody with a geo-
metric mean titer of 1:160 on day 210, or a 4-fold 
or greater titer as compared to those observed on 
day 30 or 60 after the primary inoculation and 
booster. All cranes were still positive on day 255, 
but titers were 4-fold lower, and by day 470 only 
3 of 14 cranes had detectable antibody. A third (Le., 
the annual) booster given on day 470 resulted in 
the production of detectable antibody in 7 of 12 
cranes at day 500 and in 14 of 14 cranes on days 
560 and 817. The geometric mean titer for the last 
2 dates was 1:80 and 1:40, respectively. 
DISCUSSION 
Results of larval surveys indicated that there 
were C. melanura at FGGM within 4 km of the 
Center's crane propagation area. This population 
could have been instrumental in causing the 1984 
EEE epizootic. However, adult C. melanura popu-
lations in the study area, during 3 years of post-
outbreak surveillance, were low compared to 
population levels observed on Maryland's Eastern 
Shore, an area where EEE virus is endemic (Joseph 
& Bickley 1969; Scott et al. 1987). The large num-
1 9 8 8 C R A N 
ber of C. me/anura present (34.2% of all mosquitos 
collected) on the study area merits attention and 
further evaluation, since this species has been re-
ported to be an important epidemic vector for EEE 
v.irus (Engemann 1982). Larval control (Hayes 
1962) may have merit in managing C. melanura 
populations at the Center and FGGM because of 
the limited number of prod uction sites and the en-
vironmental concerns associated with adulticides. 
Adulticiding may be of some value during emer-
gency conditions, but multiple treatments of 
broader areas would be needed and vehicle access 
to areas near production sites would be difficult. 
Chemical adulticiding should only be considered 
if early viral activity is detected through sentinel 
bird surveillance, large vector numbers are de-
tected through adult mosquito surveillance, and 
larval control proves ineffective in suppressing C. 
melanura populations. 
No seroconversions occurred in the bobwhite 
sentinels at the Center from 1985-1987. Because 
bobwhite have been effective sentinels for monitor-
ing EEE virus transmission in other studies (Wil-
liams et al. 1972), sentinel bobwhites will continue 
to be used in EEE virus management activities at 
the Center. 
The EIA technique was successful in rapidly 
detecting EEE viral antigen in crane sera. Although 
no evidence of virus activity was detected in C. 
melanura collected at the Center in 1985, virus iso-
lation and identification results were in complete 
accord with more laborious and time-consuming 
cell culture assays systems (i.e. positives were cor-
rectly identified and there were no false positives 
or false negatives). The results indicate the antigen 
detected EIA is a simple, sensitive and specific al-
ternative to traditional bioassays for EEE virus iso-
lation (Hildreth & Beaty 1984; Hildreth et al. 1984; 
Scott & Olson 1986; Hildreth & Beaty 1987; Scott 
et al. 1987; Scott et al. in press). The technique is a 
valuable addition to the procedures currently avail-
able for detection of EEE virus activity near the 
whooping crane flock. 
Data generated in the vaccination studies re-
vealed that a formalin-inactivated human EEE vi-
ral vaccine elicited N antibody in both sandhill and 
whooping cranes (Clark et a1. 1987). Whether 
whooping cranes are protected against natural in-
fection has not been ascertained, but the results 
indicated that EEE viral N antibody titers induced 
by the vaccine are indicative of a protective state, 
and therefore should minimize the risk of captive 
cranes to EEE viral infection. The vaccine is readily 
available, inexpensive, and has not caused any 
E 
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apparent adverse effects in cranes when adminis-
tered 1M. In addition, the program can be operated 
with limited resources, as antibody can be elicited 
in the cranes by a primary inoculation followed by 
a 30 day booster and can be sustained by only 1 or 
2 annual boosters. 
The epizootic of EEE virus in captive whooping 
cranes represented the most significant loss of cap-
tive whooping cranes ever experienced and re-
sulted in recognition of a potentially significant risk 
to the successful recovery of this species. However, 
through continuation of the (1) mosquito surveil-
lance and serological surveillance programs, (2) use 
of the rapid hnmunoassay, and (3) annual use of 
the EEE virus vaccine, a program to monitor EEE 
virus activity and to prevent future EEE viral in-
fections in this endangered species can be success-
ful. Depending on mosquito and viral surveillance 
results, mosquito control procedures may be use-
ful adjuncts to the aforementioned prevention 
strategies. 
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198 8 eRA N E WORKSHOP 
Table 1. Mosquitoes collected during the EEE viral surveillance program at the Patuxent Wildlife Re-
search Center and Fort George G. Meade, Maryland. 
Year 
Species 1985 1986 1987 Total (%) 
Aedes spp. 4,124 878 2,771 7,773 (6.4) 
Anopheles bradleyi-crucians 4,899 1,979 2,698 9,576 (7.8) 
Anopheles punctipennis 2,856 1,550 1,749 6,155 (5.0) 
Anopheles quadrimaculatus 2,659 372 926 3,957 (3.2) 
Coquillatidia perturbans 30,404 5,087 6,305 41,796 (34.2) 
Culex erraticus 11,830 3,543 5,270 20,643 (16.9) 
Culex salinarius 2,925 1,970 3,341 8,236 (6.7) 
Other Culex spp. 2,791 1,465 4,494 8,750 (7.2) 
Culiseta melanura 1,653 563 583 2,799 (2.3) 
Other species or mosquitoes 9,209 768 2,373 12,350 (10.1) 
not identified to species 
Total 73,350 18,175 30,510 122,035 
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